Endocrine disorders in chronic kidney disease

IF 0.1 Q4 PEDIATRICS
Joanna Sobolewska, Zuzanna Żak, Kamila Monia-Tutur, Agnieszka Wojciechowska-Luźniak, P. Witek, S. Niemczyk
{"title":"Endocrine disorders in chronic kidney disease","authors":"Joanna Sobolewska, Zuzanna Żak, Kamila Monia-Tutur, Agnieszka Wojciechowska-Luźniak, P. Witek, S. Niemczyk","doi":"10.15557/pimr.2022.0031","DOIUrl":null,"url":null,"abstract":"The increasing prevalence of chronic kidney disease gives rise to many diagnostic challenges in the daily care of this group of patients. This paper presents the most clinically significant endocrine disorders accompanying chronic kidney disease, their aetiology, diagnosis, clinical picture and treatment. Endocrine disorders may occur in patients with chronic kidney disease with greater or equal frequency as in the general population. The most important endocrine disorders include: low triiodothyronine syndrome, subclinical and overt hypothyroidism, hypercortisolaemia, hyperprolactinaemia, increased levels of growth hormone, hyperinsulinaemia, insulin resistance and hypogonadism. Hyperthyroidism and autoimmune thyroid disease occur with the same frequency in patients with chronic kidney disease as in the general population. Chronic kidney disease also affects commonly used hormone determinations. The choice of the therapeutic method in patients with chronic kidney disease is not without importance for endocrine disorders. Among patients undergoing dialysis therapy, a temporary increase in free thyroid hormones, a decrease in the severity of hypercortisolaemia and a decrease in hormone levels were observed. Dialysis therapy does not normalise prolactin levels, unlike kidney transplantation, where an improvement in glomerular filtration rate results in the normalisation of serum prolactin. The therapeutic management of some of the presented endocrine disorders is not based on a causal effect, but mainly on controlling their complications (e.g. secondary to hypercortisolaemia – hypertension, diabetes, osteopenia or abdominal obesity). In the remaining cases, hormone replacement therapy was associated with a beneficial effect for the patient: testosterone replacement in obese men with hypogonadism led to a decrease in body mass index, and cyclical transdermal hormone replacement therapy in women with oestrogen deficiency secondary to renal failure inhibited bone demineralisation and thus prevented early osteoporosis.","PeriodicalId":42380,"journal":{"name":"Pediatria i Medycyna Rodzinna-Paediatrics and Family Medicine","volume":" ","pages":""},"PeriodicalIF":0.1000,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatria i Medycyna Rodzinna-Paediatrics and Family Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15557/pimr.2022.0031","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

The increasing prevalence of chronic kidney disease gives rise to many diagnostic challenges in the daily care of this group of patients. This paper presents the most clinically significant endocrine disorders accompanying chronic kidney disease, their aetiology, diagnosis, clinical picture and treatment. Endocrine disorders may occur in patients with chronic kidney disease with greater or equal frequency as in the general population. The most important endocrine disorders include: low triiodothyronine syndrome, subclinical and overt hypothyroidism, hypercortisolaemia, hyperprolactinaemia, increased levels of growth hormone, hyperinsulinaemia, insulin resistance and hypogonadism. Hyperthyroidism and autoimmune thyroid disease occur with the same frequency in patients with chronic kidney disease as in the general population. Chronic kidney disease also affects commonly used hormone determinations. The choice of the therapeutic method in patients with chronic kidney disease is not without importance for endocrine disorders. Among patients undergoing dialysis therapy, a temporary increase in free thyroid hormones, a decrease in the severity of hypercortisolaemia and a decrease in hormone levels were observed. Dialysis therapy does not normalise prolactin levels, unlike kidney transplantation, where an improvement in glomerular filtration rate results in the normalisation of serum prolactin. The therapeutic management of some of the presented endocrine disorders is not based on a causal effect, but mainly on controlling their complications (e.g. secondary to hypercortisolaemia – hypertension, diabetes, osteopenia or abdominal obesity). In the remaining cases, hormone replacement therapy was associated with a beneficial effect for the patient: testosterone replacement in obese men with hypogonadism led to a decrease in body mass index, and cyclical transdermal hormone replacement therapy in women with oestrogen deficiency secondary to renal failure inhibited bone demineralisation and thus prevented early osteoporosis.
慢性肾脏疾病的内分泌紊乱
慢性肾脏疾病患病率的增加给这类患者的日常护理带来了许多诊断挑战。本文介绍了慢性肾脏病伴发的最具临床意义的内分泌紊乱,它们的病因、诊断、临床表现和治疗。内分泌紊乱可能发生在患有慢性肾脏疾病的患者身上,其频率与普通人群的频率更高或相等。最重要的内分泌紊乱包括:低三碘甲状腺原氨酸综合征、亚临床和显性甲状腺功能减退、皮质醇血症、高泌乳素血症、生长激素水平升高、高胰岛素血症、胰岛素抵抗和性腺功能减退。甲状腺功能亢进和自身免疫性甲状腺疾病在慢性肾脏疾病患者中的发生频率与普通人群相同。慢性肾脏疾病也会影响常用的激素测定。慢性肾脏疾病患者治疗方法的选择对内分泌紊乱并非没有重要性。在接受透析治疗的患者中,观察到游离甲状腺激素暂时增加,高皮质醇血症的严重程度降低,激素水平下降。透析治疗不能使催乳素水平正常化,这与肾移植不同,肾移植中肾小球滤过率的提高会导致血清催乳素的正常化。一些内分泌紊乱的治疗管理不是基于因果效应,而是主要基于控制其并发症(例如继发于高皮质醇血症——高血压、糖尿病、骨质减少或腹部肥胖)。在其余病例中,激素替代疗法对患者有有益影响:患有性腺功能减退症的肥胖男性的睾酮替代会导致体重指数下降,而肾功能衰竭后雌激素缺乏的女性的周期性透皮激素替代疗法会抑制骨脱矿,从而预防早期骨质疏松症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.50
自引率
0.00%
发文量
33
审稿时长
20 weeks
期刊介绍: PEDIATRIA I MEDYCYNA RODZINNA is a peer-reviewed scientific journal publishing original articles that constitute significant contributions to the advancements of paediatrics and family medicine. In addition, PEDIATRIA I MEDYCYNA RODZINNA, publishes information from the medical associations, reports and materials from international congresses, letters to the Editor, information on new medical products as well as abstracts and discussions on papers published in other scientific journals, reviews of books and other publications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信